Cigna Investments Inc Halozyme Therapeutics, Inc. Transaction History

Cigna Investments Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 06, 2019	SELL	$13.33 - $18.66 $196,404 - $274,936	-14,734 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$16.68 - $18.41 $1.11 Million - $1.22 Million	-66,308 Reduced 81.82%	14,734 $229,000
Q2 2018 Aug 14, 2018	BUY	$16.87 - $20.3 $1.11 Million - $1.33 Million	65,738 Added 429.55%	81,042 $1.37 Million
Q1 2018 May 09, 2018	BUY	$17.06 - $21.2 $261,086 - $324,444	15,304 New	15,304 $299,000

542

125M

294K

180K

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $7.35B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

Get notified when there are updates to the investment portfolio of Cigna Investments Inc , based on Form 13F filings with the SEC.

Stay updated on Cigna Investments Inc with notifications on news.